assessing the role of daratumumab in all
Published 1 year ago • 48 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
5:07
daratumumab in the management of al amyloidosis
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:20
phase ii study investigating the efficacy of daratumumab in patients with stage 3b al amyloidosis
-
2:29
evaluating the combination of nivolumab and lenalidomide in relapsed hl and lbcl
-
2:08
novel drug delivery method to prevent daratumumab infusion-related reactions in mm
-
1:21
daratumumab with atra in r/r mm
-
1:48
a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis
-
0:54
the experience of single-agent daratumumab for r/r myeloma in india
-
4:12
what is interim analysis in clinical trials ?
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
4:32
how do i know the stage of my myeloma?
-
3:27
case study: daratumumab in a relapsed patient
-
1:03
columba study update: subcutaneous daratumumab in r/r mm
-
3:35
assessment of response in mm: challenges and advances
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
-
1:05
an overview of the radar trial
-
2:04
a novel mechanism of action for daratumumab in myeloma
-
2:46
single use daratumumab for al amyloidosis
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
2:32
updates on the use of melflufen in r/r multiple myeloma
-
5:46
determination: results & implications in clinical practice
-
2:44
second interim analysis of the emn02 trial